NCT04850573 is a NA clinical trial of equine assisted activities in Stress Disorders, Post-Traumatic, sponsored by Rutgers, The State University of New Jersey.

Who is sponsoring NCT04850573?

NCT04850573 is sponsored by Rutgers, The State University of New Jersey.

What drugs are being tested in NCT04850573?

Interventions in NCT04850573: equine assisted activities.

What condition does NCT04850573 study?

NCT04850573 studies Stress Disorders, Post-Traumatic.

Is NCT04850573 still recruiting?

NCT04850573 is currently completed. Last updated 3 July 2023.

Last reviewed 2023-07-03 · How we verify

NCT04850573

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Equine Assisted Activities on Veterans With Post-traumatic Stress Disorder

Completed NA Last updated 3 July 2023

What this trial tests

NA trial testing equine assisted activities in Stress Disorders, Post-Traumatic in 9 participants. Completed in 16 June 2023.

Timeline

21 June 2021

Primary endpoint
16 June 2023

16 June 2023

Quick facts

Lead sponsor	Rutgers, The State University of New Jersey
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	9
Start date	21 June 2021
Primary completion	16 June 2023
Estimated completion	16 June 2023
Sites	1 location across United States

Drugs / interventions tested

equine assisted activities

Conditions studied

Stress Disorders, Post-Traumatic — all drugs for Stress Disorders, Post-Traumatic →

Sponsor

Rutgers, The State University of New Jersey

Who can join

Adults 18 to 65, male only, with Stress Disorders, Post-Traumatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will examine the effects of eight weeks of equine assisted activities (EAA) on co-regulation, basal physiological values, and symptom severity in veterans with post-traumatic stress disorder (PTSD). Heart rate, respiration rate, surface electromyography (EMG) and plasma concentrations of cortisol, epinephrine, norepinephrine, and oxytocin will be measured at rest and during dyadic interaction tasks (human to human or human to horse) to assess effects of EAA on these measures. Additionally, standard and regularly used questionnaires will be used to monitor PTSD symptom severity during the study and 6-month follow-up period. EAA is expected to lower PTSD symptom severity, and mitigate other physiological changes associated with PTSD.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Ground-based adaptive horsemanship lessons for veterans with post-traumatic stress disorder: a randomized controlled pilot study.
Rankins EM, Quinn A, McKeever KH, Malinowski K. · · 2024 · cited 2× · PMID 38863605 · DOI 10.3389/fpsyt.2024.1390212
Heart rate variability responses of horses and veterans with post-traumatic stress disorder to ground-based adaptive horsemanship lessons: a pilot study.
Rankins EM, Faremi BE, Hartmann K, Quinn A, et al · · 2025 · PMID 40124971 · DOI 10.1093/tas/txaf019

Verify or expand the search:

Other recruiting trials for Stress Disorders, Post-Traumatic

Currently open trials in the same condition.

NCT07422077 — Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service · NA · recruiting
NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
NCT06852469 — Computational Assessment of GABA Receptor Modulation in PTSD · Phase 4 · recruiting
NCT06000475 — Enhancing Memory in CPT for PTSD · NA · recruiting
NCT06355284 — Overcontrol and Suicide in PTSD · active not recruiting

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04850573 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 3 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04850573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing